DCLRE1C
Basic information
Region (hg38): 10:14897359-14954432
Previous symbols: [ "SCIDA" ]
Links
Phenotypes
GenCC
Source:
- severe combined immunodeficiency due to DCLRE1C deficiency (Definitive), mode of inheritance: AR
- Omenn syndrome (Limited), mode of inheritance: AR
- severe combined immunodeficiency due to DCLRE1C deficiency (Supportive), mode of inheritance: AR
- Omenn syndrome (Supportive), mode of inheritance: AR
- severe combined immunodeficiency due to DCLRE1C deficiency (Strong), mode of inheritance: AR
- severe combined immunodeficiency due to DCLRE1C deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Omenn syndrome; Severe combined immunodeficiency with sensitivity to ionizing radiation | AR | Allergy/Immunology/Infectious | Individuals typically present early in life with sequelae of infections, which are typically frequent and can be severe, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; HSCT may be beneficial | Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal | 12055248; 12569164; 15731174; 19912631; 21184155 |
ClinVar
This is a list of variants' phenotypes submitted to
- Severe combined immunodeficiency due to DCLRE1C deficiency (57 variants)
- Histiocytic medullary reticulosis (10 variants)
- not provided (4 variants)
- Athabaskan severe combined immunodeficiency (3 variants)
- Severe combined immunodeficiency due to DCLRE1C deficiency;Histiocytic medullary reticulosis (2 variants)
- Severe combined immunodeficiency disease (2 variants)
- Severe combined immunodeficiency, partial (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCLRE1C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 291 | 295 | ||||
missense | 11 | 242 | 272 | |||
nonsense | 24 | 16 | 44 | |||
start loss | 1 | |||||
frameshift | 25 | 30 | 63 | |||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 26 | 35 | ||||
splice region | 2 | 14 | 56 | 72 | ||
non coding | 51 | 127 | 21 | 199 | ||
Total | 59 | 83 | 311 | 427 | 32 |
Highest pathogenic variant AF is 0.0000395
Variants in DCLRE1C
This is a list of pathogenic ClinVar variants found in the DCLRE1C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-14897387-C-G | not specified | Uncertain significance (May 21, 2024) | ||
10-14897449-C-T | not specified | Likely benign (Jul 21, 2021) | ||
10-14899056-T-G | not specified | Benign (Jan 24, 2024) | ||
10-14899187-G-A | Likely benign (Oct 01, 2023) | |||
10-14899206-G-C | Likely benign (Nov 01, 2023) | |||
10-14899234-C-T | Severe combined immunodeficiency due to DCLRE1C deficiency • Histiocytic medullary reticulosis • not specified | Benign (Jan 24, 2024) | ||
10-14899244-C-G | SUV39H2-related disorder | Likely benign (Jun 05, 2019) | ||
10-14899283-G-A | DCLRE1C-related disorder | Likely benign (Jun 20, 2019) | ||
10-14899533-G-C | Benign (Mar 29, 2018) | |||
10-14899588-A-G | not specified | Uncertain significance (Sep 12, 2023) | ||
10-14902418-T-C | not specified | Uncertain significance (May 24, 2024) | ||
10-14902438-C-G | not specified | Uncertain significance (Oct 05, 2023) | ||
10-14906873-T-C | Histiocytic medullary reticulosis | Uncertain significance (Jan 13, 2018) | ||
10-14906883-T-A | Histiocytic medullary reticulosis | Uncertain significance (Jan 13, 2018) | ||
10-14906921-C-G | Histiocytic medullary reticulosis | Uncertain significance (Jan 13, 2018) | ||
10-14906956-C-T | Histiocytic medullary reticulosis | Uncertain significance (Jan 12, 2018) | ||
10-14907000-C-T | Histiocytic medullary reticulosis | Uncertain significance (Jan 13, 2018) | ||
10-14907001-G-A | Histiocytic medullary reticulosis | Uncertain significance (Jan 13, 2018) | ||
10-14907014-G-A | Histiocytic medullary reticulosis | Uncertain significance (Jan 13, 2018) | ||
10-14907018-A-C | Histiocytic medullary reticulosis | Uncertain significance (Jun 14, 2016) | ||
10-14907018-A-G | Histiocytic medullary reticulosis | Benign (Jan 13, 2018) | ||
10-14907069-C-G | Histiocytic medullary reticulosis | Benign (Jan 13, 2018) | ||
10-14907121-A-G | Histiocytic medullary reticulosis | Benign (Jan 13, 2018) | ||
10-14907128-G-A | Histiocytic medullary reticulosis | Uncertain significance (Jan 13, 2018) | ||
10-14907132-G-C | Histiocytic medullary reticulosis | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DCLRE1C | protein_coding | protein_coding | ENST00000378278 | 14 | 57074 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.49e-7 | 0.999 | 125583 | 0 | 165 | 125748 | 0.000656 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.678 | 391 | 355 | 1.10 | 0.0000180 | 4540 |
Missense in Polyphen | 99 | 114.48 | 0.86475 | 1463 | ||
Synonymous | -2.14 | 161 | 130 | 1.24 | 0.00000688 | 1285 |
Loss of Function | 2.92 | 17 | 35.9 | 0.474 | 0.00000192 | 455 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000781 | 0.000778 |
Ashkenazi Jewish | 0.00248 | 0.00248 |
East Asian | 0.000489 | 0.000489 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000502 | 0.000501 |
Middle Eastern | 0.000489 | 0.000489 |
South Asian | 0.00124 | 0.00124 |
Other | 0.00245 | 0.00245 |
dbNSFP
Source:
- Function
- FUNCTION: Required for V(D)J recombination, the process by which exons encoding the antigen-binding domains of immunoglobulins and T-cell receptor proteins are assembled from individual V, (D), and J gene segments. V(D)J recombination is initiated by the lymphoid specific RAG endonuclease complex, which generates site specific DNA double strand breaks (DSBs). These DSBs present two types of DNA end structures: hairpin sealed coding ends and phosphorylated blunt signal ends. These ends are independently repaired by the non homologous end joining (NHEJ) pathway to form coding and signal joints respectively. This protein exhibits single-strand specific 5'-3' exonuclease activity in isolation and acquires endonucleolytic activity on 5' and 3' hairpins and overhangs when in a complex with PRKDC. The latter activity is required specifically for the resolution of closed hairpins prior to the formation of the coding joint. May also be required for the repair of complex DSBs induced by ionizing radiation, which require substantial end-processing prior to religation by NHEJ. {ECO:0000269|PubMed:11336668, ECO:0000269|PubMed:11955432, ECO:0000269|PubMed:12055248, ECO:0000269|PubMed:14744996, ECO:0000269|PubMed:15071507, ECO:0000269|PubMed:15456891, ECO:0000269|PubMed:15468306, ECO:0000269|PubMed:15574326, ECO:0000269|PubMed:15574327, ECO:0000269|PubMed:15811628, ECO:0000269|PubMed:15936993}.;
- Disease
- DISEASE: Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-negative/NK-cell-positive with sensitivity to ionizing radiation (RSSCID) [MIM:602450]: A form of severe combined immunodeficiency, a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T- cell-mediated cellular immunity due to a defect in T-cell development. Individuals affected by RS-SCID show defects in the DNA repair machinery necessary for coding joint formation and the completion of V(D)J recombination. A subset of cells from such patients show increased radiosensitivity. {ECO:0000269|PubMed:11336668, ECO:0000269|PubMed:12406895, ECO:0000269|PubMed:12569164, ECO:0000269|PubMed:12592555, ECO:0000269|PubMed:12921762}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Severe combined immunodeficiency Athabaskan type (SCIDA) [MIM:602450]: A variety of SCID with sensitivity to ionizing radiation. A founder mutation has been detected in Athabascan- speaking native Americans, being inherited as an autosomal recessive trait. Affected individuals exhibit clinical symptoms and defects in DNA repair comparable to those seen in RS-SCID. {ECO:0000269|PubMed:12055248}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Omenn syndrome (OS) [MIM:603554]: Severe immunodeficiency characterized by the presence of activated, anergic, oligoclonal T-cells, hypereosinophilia, and high IgE levels. {ECO:0000269|PubMed:15731174}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Primary immunodeficiency - Homo sapiens (human);Non-homologous end-joining - Homo sapiens (human);ATM Signaling Network in Development and Disease;DNA Repair;Nonhomologous End-Joining (NHEJ);DNA Double-Strand Break Repair;ATM pathway;DNA-PK pathway in nonhomologous end joining
(Consensus)
Recessive Scores
- pRec
- 0.206
Intolerance Scores
- loftool
- 0.908
- rvis_EVS
- 0.07
- rvis_percentile_EVS
- 59.04
Haploinsufficiency Scores
- pHI
- 0.218
- hipred
- Y
- hipred_score
- 0.718
- ghis
- 0.524
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.893
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dclre1c
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- adaptive immune response;double-strand break repair via nonhomologous end joining;response to ionizing radiation;B cell differentiation;protection from non-homologous end joining at telomere;V(D)J recombination;interstrand cross-link repair;nucleic acid phosphodiester bond hydrolysis
- Cellular component
- nuclear chromosome, telomeric region;nucleoplasm;Golgi apparatus;nonhomologous end joining complex
- Molecular function
- single-stranded DNA endodeoxyribonuclease activity;damaged DNA binding;endonuclease activity;protein binding;5'-3' exonuclease activity;5'-3' exodeoxyribonuclease activity